• Borie A
  • PV 236
  • Juin 2003
  • : Chien, chat

1. ATKINS CE, GALLO AM, KURZMAN ID, COWEN P. Risk factors, clinical signs, and survival in cats with a clinical diagnosis of idiopathic hypertrophic cardiomyopathy: 74 cases (1985-1989). J. Am. Vet. Med. Assoc.1992; 201(4):613-618.
2. BATY CJ, HARDIE EM. Pulmonary thromboembolism: diagnosis and treatment. In: KIRK RW, BONAGURA JD. Current Veterinary Therapy XI Small Animal Practice. Philadelphia, WB Saunders.1992:137-142.
3. BEAUGHARD M, BRASSET M, JOHN G, MASSINGHAM R. Failure of calcium channel blockade to reduce platelet-mediated cyclic flow variations in dogs with coronary stenosis and endothelial injury. J. Cardiovasc. Pharmacol. 1995;26(4):577-583.
4. BEHREND EN, GRAUER GF, GRECO DS, ROSE BJ, THRALL MAH. Comparison of the effects of diltiazem and aspirin on platelet aggregation in cats. J. Am. Anim. Hosp. Assoc.1996;32:11-18.
5. BONAGURA JD, FOX PR. Restrictive cardiomyopathy. In: KIRK RW, BONAGURA JD. Current Veterinary Therapy XII Small Animal Practice. Philadelphia, WB Saunders.1995:863-867.
6. BOOTHE DM. Prostaglandins: physiology and clinical implications. Compend. Contin. Educ. Pract. Vet.1984;6(11):1010-1021.
7. BOUDREAUX MK, DILLON AR. Platelet function, antithrombin-III activity, and fibrinogen concentration in heartworm-infected and heartworm-negative dogs treated with thiacetarsamide. Am. J. Vet. Res. 1991;52(12):1986-1991.
8. BOUDREAUX MK, DILLON AR, SPANO JS. Enhanced platelet reactivity in heartworm-infected dogs. Am. J. Vet. Res. 1989;50(9):1544-1547.
9. BURNS MG, KELLY AB, HORNOF WJ, HOWERTH EW. Pulmonary artery thrombosis in three dogs with hyperadrenocorticism. J. Am. Vet. Med. Assoc. 1981;178 (4):388-393.
10. CARR AP, JONNSON GS. A review of hemostatic abnormalities in dogs and cats. J. Am. Anim. Hosp. Assoc. 1994;30:475-482.
11. CARTER AJ, VAN HEERDEN J. Aortic thrombosis in a dog with glomerulonephritis. J. S. Afr. Vet. Ass. 1994;65(4):189-192.
12. CHETBOUL V. Le chat cardiaque. Rec. Méd. Vét. 1987;163(8-9):807-817.
13. CHETBOUL V, DEVAUCHELLE P. Thromboembolie pulmonaire chez les carnivores. Le Point Vét. 1995;27:463-475.
14. CHRISTOPHER MM. Hematologic complications of diabetes mellitus. Vet. Clin. North Am. Small Anim. Pract. 1995;25(3):625-637.
15. CLARE AC, KRAJE BJ. Use of recombinant tissue-plasminogen activator for aortic thrombolysis in a hypoproteinemic dog. J. Am. Vet. Med. Assoc. 1998;212(4):539-543.
16. CLEMENTS CA, ROGERS KS, GREEN RA, LOY JK. Splenic vein thrombosis resulting in acute anemia: an anusual manifestation of nephrotic syndrome in a chinese Shar Pei with reactive amyloidosis. J. Am. Anim. Hosp. Assoc. 1995;31:411-415.
17. CORLOUER JP. Thromboembolie pulmonaire chez le chien. Pract. Méd. Chir. Anim. Comp. 1994;29:71-84.
18. DAVENPORT DJ, BREITSCHWERDT EB, CARAKOSTAS MC. Platelet disorders in the dog and cat. Part I: Physiology and pathogenesis. Compend. Contin. Educ. Pract. Vet. 1982;4(9):762-772.
19. DIBARTOLA SP, MEUTEN DJ. Renal amyloidosis in two dogs presented for thromboembolic phenomena. J. Am. Anim. Hosp. Assoc. 1980;16:129-135.
20. DUESBERG CA, NELSON RW, FELDMAN EC, VADEN SL, SCOTT-MONCRIEFF CR. Adrenalectomy for treatment of hyperadrenocorticism in cats: 10 cases (1988-1992). J. Am. Vet. Med. Assoc. 1995;207(8):1066-1070.
21. DUHAUTOIS B, NICOLLET P, DELBARY N, DEBAERT M. Traitement chirurgical d'un cas de thrombo-embolie aortique féline. Pract. Méd. Chir. Anim. Comp. 1998;33:163-174.
22. FELDMAN BF, RASEDEE A. Haemostatic abnormalities in canine cushing's syndrome. Res. Vet. Sci. 1986;41:228-230.
23. FELDMAN EC. Adrenal gland disease. In:ETTINGER SJ. Texbook of Veterinary Internal Medicine. Diseases of the dog and the cat. 3rd ed. Philadelphia, WB Saunders. 1989:1721-1774.
24. FELDMAN EC, NELSON RW. Hyperadrenocorticism. In: FELDMAN EC, NELSON RW. Canine and Feline Endocrinology and Reproduction. 2nd ed. Philadelphia, WB Saunders. 1996:187-265.
25. FLANDERS JA. Feline aortic thromboembolism. Compend. Contin. Educ. Pract. Vet. 1986;8(7):473-484.
26. GRECO DS, GREEN RA. Coagulations abnormalities associated with thrombosis in a dog with nephrotic syndrome. Compend. Contin. Educ. Pract. Vet. 1987;9(6):653-658.
27. GREEN RA. Activated coagulation time in monitoring heparinized dogs. Am. J. Vet. Res. 1980;41(11):1793-1797.
28. GREEN RA. Clinical implications of antithrombin III deficiency in animal diseases. Compend. Contin. Educ. Pract. Vet. 1984;(6):537-545.
29. GREEN RA. Pathophysiology of antithrombin III deficiency. Vet. Clin. North Am. Small Anim. Pract. 1988;18(1):95-104.
30. GREEN RA, KABEL AL. Hypercoagulable state in three dogs with nephrotic syndrome: Role of acquired antithrombin III deficiecy. J. Am. Vet. Med. Assoc. 1982;181(9):914-917.
31. GREEN RA, THOMAS JS. Hemostatic disorders: coagulopathies and thrombosis. In: ETTINGER SJ, FELDMAN EC. Texbook of Veterinary Internal Medicine. Diseases of the dog and the cat. 4th ed. Philadelphia, WB Saunders. 1995:1946-1963.
32. GREEN RA, RUSSO EA, GREENE RT, KABEL AL. Hypoalbuminemia-related platelet hypersensitivity in two dogs with nephrotic syndrome. J. Am. Vet. Med. Assoc. 1985;186(5):485-488.
33. HARGIS AM, STEPHENS LC, BENJAMIN SA, BREWSTER RD, BROOKS RK. Relationship of hypothyroidism to diabete mellitus, renal amyloidosis, and thrombosis in purebred beagles. Am. J. Vet. Res. 1981;42(6):1077-1081.
34. HARPSTER NK. Feline myocardial diseases. In: KIRK RW, BONAGURA JD. Current Veterinary Therapy IX Small Animal Practice. Philadelphia, WB Saunders. 1986:380-398.
35. HARPSTER NK, BATY CJ. Warfarin therapy of the cat at risk of thromboembolism. In: KIRK RW, BONAGURA JD. Current Veterinary Therapy XII Small Animal Practice. Philadelphia, WB Saunders. 1995:868-873.
36. HELENSKI CA, ROSS JN. Platelet aggregation in feline cardiomyopathy. J. Vet. Int. Med. 1987;1(1):24-28
37. IHLE SL, BALDWIN CJ, PIFER SM. Probable recurrent femoral artery thrombosis in a dog with intestinal lymphosarcoma. J. Am. Vet. Med. Assoc. 1996;208(2):240-242.
38. JOHNSON LR, HAMLIN RL. Recognition and treatment of pulmonary hypertension. In: KIRK RW, BONAGURA JD. Current Veterinary Therapy XII Small Animal Practice. Philadelphia, WB Saunders. 1995:887-892.
39. JOHNSON LR, LAPPIN MR. Clinical features of fatal pulmonary thromboembolism:1985-1995. J. Vet. Int. Med. 1996;10:162.
40. KEITH JC, RAWLINGS CA, SCHAUB RG. Pulmonary thromboembolism during therapy of dirofilariasis with thiacetarsamide: modification with aspirin or prednisolone. Am. J. Vet. Res. 1983;44(7):1278-1283.
41. KEROACK S, CADORE JL. Diagnostic et traitement de la CIVD. Point Vét., 1999;30(202):531-538.
42. KILLINGSWORTH CR, EYSTER GE, ADAMS T, BARTLETT PC, BELL TG. Streptokinase treatement of cats with experimentally induced aortic thrombosis. Am. J. Vet. Res. 1986;47(6):1351-1359.
43. KLEIN MK, DOW SW, ROSYCHUK RA. Pulmonary thromboembolism associated with immune-mediated hemolytic anemia in dogs: ten cases (1982-1987). J. Am. Vet. Med. Assoc. 1989;195(2):246-250.
44. LARUE MJ, MURTAUGH RJ. Pulmonary thromboembolism in dogs: 47 cases (1986-1987). J. Am. Vet. Med. Assoc. 1990;197(10):1368-1372.
45. LASTE NJ, HARPSTER NK. A retrospective study of 100 cases of feline distal aortic thromboembolism: 1977-1993. J. Am. Anim. Hosp. Assoc. 1995;31:492-500.
46. MANNING PJ. Thyroid gland and arterial lesions of beagles with familial hypthyroidism and hyperlipoproteinemia. Am. J. Vet. Res. 1979;4(6):820-828.
47. NICHOLS R. Concurrent illness and complications associated with canine hyperadrenocorticism. Prob. Vet. Med. 1990;2:565-573.
48. NICHOLS R. Complications and concurrent disease associated with canine hyperadrenocorticism. Vet. Clin. North Am. Small Anim. Pract. 1997;27(2):309-320.
49. O'KEEFE DA, COUTO CG. Coagulation abnormalities associated with neoplasia. Vet. Clin. North Am. Small Anim. Pract. 1988;18(1):157-168.
50. ORTEGA T, FELDMAN E, COWGILL L, NELSON R, FELDMAN M. Evaluation of arterial blood pressure and urine protein creatinine ratio in dogs with canine Cushing's syndrome. J. Vet. Int. Med. 1994;8:164.
51. ORTEGA TM, FELDMAN EC, NELSON RW, WILLITS N, COWGILL LD. Systemic arterial blood pressure and urine protein/creatinine ratio in dogs with hyperadrenocorticism. J. Am. Vet. Med. Assoc. 1996;209(10):1724-1729.
52. ORTEGA TM, FELDMAN EC, OWINGS JT, GOSSELIN R, NELSON RW. Hypercoagulopathy in dogs with hyperadrenocorticism. J. Vet. Int. Med. 1996;10:185.
53. PALMER KG, KING LG, VAN WINKLE TJ. Clinical manifestations and associated disease syndromes in dogs with cranial vena cava thrombosis: 17 cases (1989-1996). J. Am. Vet. Med. Assoc. 1998;213(2):220-224.
54. PATRONO C. Aspirin as an antiplatelet drug. N. Engl. J. Med. 1994;330(18):1287-1294.
55. PION PD. Feline aortic thromboemboli and the potential utility of thrombolytic therapy with tissue plasminogen activator. Vet. Clin. North Am. Small Anim. Pract. 1988;18(1):79-86.
56. PION PD, KITTLESON MD. Therapy for feline aortic thromboembolism. In: KIRK RW, BONAGURA JD. Current Veterinary Therapy X Small Animal Practice. Philadelphia, WB Saunders. 1989:295-302.
57. POUCHELON JL, CHETBOUL V, DEVAUCHELLE P, DELISLE F, MAI W, VIAL V. Diagnosis of pulmonary thromboembolism in a cat using echocardiography and pulmonary scintigraphy. J. Small Anim. Pract. 1997;38:306-310.
58. RAMSEY CC, BURNEY DP, MACINTIRE DK, FINN-BODNER S. Use of streptokinase in four dogs with thrombosis. J. Am. Vet. Med. Assoc. 1996;209(4):780-784.
59. RAWLINGS CA, CALVERT CA. Heartworm disease. In: ETTINGER SJ, FELDMAN EC. Texbook of Veterinary Internal Medicine. Diseases of the dog and the cat. 4th ed. Philadelphia, WB Saunders. 1995:1046-1068.
60. RAWLINGS CA, KEITH JC, LOSONSKY JM, LEWIS RE, MC CALL JW. Aspirin and prednisolone modification of postadulticide pulmonary arterial disease in heartworm-infected dogs: arteriography study. Am. J. Vet. Res. 1983;44(5):821-827.
61. RAWLINGS CA, RAYNAUD JP, LEWIS RE, DUNCAN JR. Pulmonary thromboembolism and hypertension after thiacetarsamide vs melarsonine dihydrochloride treatment of Dirofilaria immitis infection in dogs. Am. J. Vet. Res. 1993;54(6):920-925.
62. RELFORD RL, GREEN RA. Coagulation disorders in glomerular diseases. In: KIRK RW, BONAGURA JD. Current Veterinary Therapy XI Small Animal Practice. Philadelphia, WB Saunders. 1992:827-829.
63. RELFORD RL, LEES GE. Nephrotic syndrome in dogs: diagnosis and treatment. Compend. Contin. Educ. Pract. Vet. 1996;18(3):279-293.
64. RITT MG, ROGERS KS, THOMAS JS. Nephrotic syndrome resulting in thromboembolic disease and disseminated intravascular coagulation in a dog. J. Am. Anim. Hosp. Assoc. 1997;33:385-391.
65. ???
66. SISSON DD, THOMAS WP. Myocardial diseases. In: ETTINGER SJ, FELDMAN EC. Texbook of Veterinary Internal Medicine. Diseases of the dog and the cat. 4th ed. Philadelphia, WB Saunders. 1995:995-1032.
67. SUTER PF, FOX PR. Peripheral vascular disease. In: ETTINGER SJ, FELDMAN EC. Texbook of Veterinary Internal Medicine. Diseases of the dog and the cat. 4th ed. Philadelphia, WB Saunders, 1995, 1068-1081.
68. TROY GC. An overview of hemostasis. Vet. Clin. North Am. Small Anim. Pract. 1988;18(1):5-20.
69. VAN WINKLE TJ, BRUCE E. Thrombosis of the portal vein in eleven dogs. Vet. Pathol. 1993;30:28-35.
70. VAN WINKLE TJ, HACKNER SG, LIU SM. Clinical and pathological features of aortic thromboembolism in 36 dogs. Journal of Veterinary Emergency and Critical Care. 1993;3(1):13-21.
71. WEISS DJ, RASHID J. The sepsis- coagulant axis: a review. J. Vet. Intern. Med. 1998;12:317-324.
72. WELLES EG. Antithrombotic and fibrinolytic factors. Vet. Clin. North Am. Small Anim. Pract. 1996;26(5):1111-1127
73. WELLES EG, BOUDREAUX MK, TYLER JW. Platelet, antithrombin, and fibrinolytic activities in taurine-deficient and taurine-replete cats. Am. J. Vet. Res. 1993;54(8):1235-1243.
74. WELLES EG, BOUDREAUX MK, CRAGER CS, TYLER JW. Platelet function and antithrombin, plasminogen, and fibrinolytic activities in cats with heart disease. Am. J. Vet. Res. 1994;55(5):619-627.
75. WILLIAMSON LH. Antithrombin III: a natural anticoagulant. Compend. Contin. Educ. Pract. Vet. 1991;13(1):100-107.
76. WYSONG RL. Taurine and arterial thromboembolism. J. Am. Vet. Med. Assoc. 1989;195(11):1463-1464.


En poursuivant votre navigation sur ce site, vous acceptez l’utilisation de cookies pour vous proposer des services et offres adaptés à vos centres d’intérêts.X
Pour en savoir plus et paramétrer les cookies...